Robert I Haddad Selected Research

Robert I Haddad Research Topics

Disease

50	Neoplasms (Cancer) 09/2022 - 07/2004
35	Squamous Cell Carcinoma of Head and Neck 01/2022 - 06/2003
29	Head and Neck Neoplasms (Head and Neck Cancer) 09/2022 - 06/2003
8	Deglutition Disorders (Dysphagia) 01/2021 - 06/2006
8	Oropharyngeal Neoplasms 10/2019 - 07/2010
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 12/2009
7	Carcinoma (Carcinomatosis) 01/2021 - 12/2011
7	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019 - 12/2004
6	Thyroid Neoplasms (Thyroid Cancer) 12/2018 - 03/2008
5	Adenoid Cystic Carcinoma (Cylindroma) 01/2022 - 04/2006
5	Pathologic Constriction (Stenosis) 01/2019 - 11/2008
3	Osteoradionecrosis 01/2022 - 12/2008
3	Neutropenia 01/2021 - 10/2007
3	Anaplastic Thyroid Carcinoma 12/2018 - 10/2014
3	medullary Thyroid cancer 10/2013 - 02/2013
3	Esophageal Stenosis (Esophageal Stricture) 08/2011 - 12/2008
2	Nasopharyngeal Carcinoma 09/2022 - 12/2019
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2020 - 07/2015
2	Mucositis 01/2019 - 10/2007
2	Fatigue 04/2017 - 05/2015
2	Exanthema (Rash) 04/2017 - 05/2015
2	Stomatitis 05/2015 - 12/2013
2	Dental Caries (Decay, Dental) 03/2015 - 12/2008
2	Carcinogenesis 10/2014 - 06/2003
2	Xerostomia 08/2011 - 12/2008
2	Pathologic Complete Response 09/2010 - 05/2006
2	Neoplasm Metastasis (Metastasis) 10/2007 - 12/2004
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Rupture 01/2021
1	Inflammation (Inflammations) 01/2021
1	COVID-19 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Epistaxis (Nosebleed) 12/2019
1	Hemorrhage 10/2017
1	Asthenia 04/2017
1	Diarrhea 04/2017
1	Proteinuria 04/2017

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2003
10	Docetaxel (Taxotere)FDA Link 01/2019 - 10/2003
9	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 12/2004
7	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2010
7	Fluorouracil (Carac)FDA LinkGeneric 04/2012 - 12/2004
5	PlatinumIBA 01/2021 - 07/2012
4	CytokinesIBA 01/2018 - 01/2005
4	Cetuximab (Erbitux)FDA Link 01/2018 - 09/2009
3	Pharmaceutical PreparationsIBA 12/2019 - 10/2014
3	AfatinibIBA 01/2019 - 06/2014
3	vandetanib (ZD6474)IBA 12/2014 - 02/2013
3	Biological ProductsIBA 10/2014 - 10/2007
2	NivolumabIBA 01/2022 - 10/2020
2	pembrolizumabIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 06/2003
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2013
2	Everolimus FDA Link 01/2018 - 10/2014
2	IodineIBA 01/2018 - 12/2014
2	AntibodiesIBA 01/2017 - 07/2004
2	salicylhydroxamic acid (SHAM)IBA 12/2016 - 07/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2005
2	Tyrosine Kinase InhibitorsIBA 05/2015 - 10/2013
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 06/2014
2	ErbB Receptors (EGF Receptor)IBA 11/2012 - 01/2005
2	TubulinIBA 04/2012 - 12/2009
2	Gefitinib (Iressa)FDA Link 03/2008 - 10/2005
1	AutoantigensIBA 08/2022
1	AntigensIBA 08/2022
1	lirilumabIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	avelumabIBA 01/2021
1	IpilimumabIBA 10/2020
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Sucrose (Saccharose)IBA 01/2020
1	AndrogensIBA 01/2020
1	Azacitidine (5 Azacytidine)FDA Link 12/2019
1	cc-486IBA 12/2019
1	cemiplimabIBA 01/2019
1	cixutumumabIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2018
1	lenvatinibIBA 04/2017

Therapy/Procedure

43	Therapeutics 09/2022 - 10/2004
23	Radiotherapy 01/2022 - 08/2005
17	Induction Chemotherapy 01/2016 - 06/2003
15	Chemoradiotherapy 01/2021 - 06/2003
12	Drug Therapy (Chemotherapy) 09/2022 - 06/2003
5	Immunotherapy 08/2022 - 01/2016
4	Neck Dissection (Radical Neck Dissection) 09/2011 - 06/2005
3	Gastrostomy 01/2019 - 09/2011
3	Aftercare (After-Treatment) 01/2017 - 06/2005
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2012 - 11/2008
2	Tracheotomy 10/2017 - 02/2010
2	Re-Irradiation 10/2016 - 10/2010
2	Palliative Care (Palliative Therapy) 10/2007 - 10/2005
1	Time-to-Treatment 01/2022
1	Treatment Delay 10/2021
1	Precision Medicine 01/2018
1	Hematopoietic Stem Cell Transplantation 01/2018